Solenkova Nataliya V, Solodushko Viktoriya, Cohen Michael V, Downey James M
Dept. of Physiology, Univ. of South Alabama, College of Medicine, Mobile, AL 36688, USA.
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H441-9. doi: 10.1152/ajpheart.00589.2005. Epub 2005 Sep 9.
Ischemic preconditioning (IPC) is thought to protect by activating survival kinases during reperfusion. We tested whether binding of adenosine receptors is also required during reperfusion and, if so, how long these receptors must be populated. Isolated rabbit hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. IPC reduced infarct size from 32.1 +/- 4.6% of the risk zone in control hearts to 7.3 +/- 3.6%. IPC protection was blocked by a 20-min pulse of the nonselective adenosine receptor blocker 8-(p-sulfophenyl)-theophylline when started either 5 min before or 10 min after the onset of reperfusion but not when started after 30 min of reperfusion. Protection was also blocked by either 8-cyclopentyl-1,3-dipropylxanthine, an adenosine A1-selective receptor antagonist, or MRS1754, an A2B-selective antagonist, but not by 8-(3-chlorostyryl)caffeine, an A2A-selective antagonist. Blockade of phosphatidylinositol 3-OH kinase (PI3K) with a 20-min pulse of wortmannin also aborted protection when started either 5 min before or 10 or 30 min after the onset of reperfusion but failed when started after 60 min of reflow. U-0126, an antagonist of MEK1/2 and therefore of ERK1/2, blocked protection when started 5 min before reperfusion but not when started after only 10 min of reperfusion. These studies reveal that A1 and/or A2B receptors initiate the protective signal transduction cascade during reperfusion. Although PI3K activity must continue long into the reperfusion phase, adenosine receptor occupancy is no longer needed by 30 min of reperfusion, and ERK activity is only required in the first few minutes of reperfusion.
缺血预处理(IPC)被认为是通过在再灌注期间激活存活激酶来发挥保护作用。我们测试了再灌注期间腺苷受体的结合是否也是必需的,如果是,这些受体必须占据多长时间。将离体兔心进行30分钟的局部缺血和2小时的再灌注。IPC使梗死面积从对照心脏危险区的32.1±4.6%降至7.3±3.6%。当在再灌注开始前5分钟或开始后10分钟开始给予非选择性腺苷受体阻滞剂8-(对磺基苯基)茶碱20分钟脉冲时,IPC的保护作用被阻断,但在再灌注30分钟后开始给予则未被阻断。腺苷A1选择性受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤或A2B选择性拮抗剂MRS1754也可阻断保护作用,但A2A选择性拮抗剂8-(3-氯苯乙烯基)咖啡因则不能。用渥曼青霉素20分钟脉冲阻断磷脂酰肌醇3-羟基激酶(PI3K),在再灌注开始前5分钟或开始后10或30分钟开始给予时也会使保护作用中止,但在再灌注60分钟后开始给予则无效。MEK1/2进而ERK1/2的拮抗剂U-0126在再灌注前5分钟开始给予时可阻断保护作用,但在再灌注仅10分钟后开始给予则不能。这些研究表明,A1和/或A2B受体在再灌注期间启动保护性信号转导级联反应。尽管PI3K活性必须在再灌注期持续很长时间,但再灌注30分钟后腺苷受体的占据不再是必需的,而ERK活性仅在再灌注的最初几分钟是必需的。